genedrive plc – LSE:GDR.L

genedrive stock price today

GBP 43
+40.58
+1676.86%
Financial Health
0
1
2
3
4
5
6
7
8
9

genedrive stock price monthly change

-13.57%
month

genedrive stock price quarterly change

-13.57%
quarter

genedrive stock price yearly change

-70.23%
year

genedrive key metrics

Market Cap
 12.39M
Enterprise value
 684.79M
P/E
 -4.95
EV/Sales
 646.64
EV/EBITDA
 -35.08
Price/Sales
 6.08
Price/Book
 1.14
PEG ratio
 N/A
EPS
 -0.07
Revenue
 294K
EBITDA
 -8.59M
Income
 -8.34M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 -1833.71%
Oper. margin
 -532.58%
Gross margin
 0%
EBIT margin
 -532.58%
EBITDA margin
 -2922.79%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

genedrive stock price history

genedrive stock forecast

genedrive financial statements

Profit Margin

genedrive plc (LSE:GDR.L): Profit margin
Dec 2021 1K -1.15M -115350%
Dec 2022 21K -2.19M -10433.33%
Jun 2023 34K -2.95M -8702.94%
Dec 2023 238K -2.03M -856.72%
GDR.L income statement history

Debt to Assets

genedrive plc (LSE:GDR.L): Debt to assets
Dec 2021 9243000 1.33M 14.45%
Sep 2022 4833000 1.28M 26.63%
Dec 2022 4833000 1.37M 28.53%
Dec 2023 3439000 1.93M 56.21%
GDR.L balance sheet history

Cash Flow

genedrive plc (LSE:GDR.L): Cash Flow
Dec 2021 -2.89M 97K 6.53M
Dec 2022 -2.41M -7K -81K
Jun 2023 -1.35M -30K 1.90M
Dec 2023 -2.41M -5K 1.04M
GDR.L cash flow history

genedrive alternative data

genedrive
Employees

genedrive plc (LSE:GDR.L): Employee count
Aug 2023 40
Sep 2023 40
Oct 2023 40
Nov 2023 40
Dec 2023 40
Jan 2024 43
Feb 2024 43
Mar 2024 43
Apr 2024 43
May 2024 43
Jun 2024 43
Jul 2024 43

genedrive other data

genedrive
Executives

Insider Compensation
Mr. David Budd (1968) Chief Executive Officer & Executive Director
 $242,190
Mr. Matthew John Fowler (1975) Chief Financial Officer, Company Sec. & Executive Director
 $181,120

Frequently Asked Questions (FAQ)

  • What's the price of genedrive stock today?

    One share of genedrive stock can currently be purchased for approximately $43.

  • When is genedrive's next earnings date?

    Unfortunately, genedrive's (GDR.L) next earnings date is currently unknown.

  • Does genedrive pay dividends?

    No, genedrive does not pay dividends.

  • How much money does genedrive make?

    genedrive has a market capitalization of 12.39M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 922.45% to 501K US dollars.

  • What is genedrive's stock symbol?

    genedrive plc is traded on the LSE under the ticker symbol "GDR.L".

  • What is genedrive's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of genedrive?

    Shares of genedrive can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are genedrive's key executives?

    genedrive's management team includes the following people:

    • Mr. David Budd Chief Executive Officer & Executive Director(age: 57, pay: $242,190)
    • Mr. Matthew John Fowler Chief Financial Officer, Company Sec. & Executive Director(age: 50, pay: $181,120)

  • How many employees does genedrive have?

    As Jul 2024, genedrive employs 43 workers.

  • When genedrive went public?

    genedrive plc is publicly traded company for more then 18 years since IPO on 4 Apr 2007.

  • What is genedrive's official website?

    The official website for genedrive is genedriveplc.com.

  • How can i contact genedrive?

    genedrive can be reached via phone at +44 161 989 0245.

genedrive company profile:

genedrive plc

genedriveplc.com
Exchange:

LSE

Full time employees:

43

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

+44 161 989 0245
The CTF Building
Manchester, M13 9XX

:
ISIN: GB00B1VKB244
CUSIP: G3791Q102